Item 7.01 Regulation FD Disclosure

On September 22, 2021, Bionik Laboratories Corp. issued a press release announcing that hospitals and other healthcare facilities utilizing InMotion Connect™ have seen a 72% increase in patient sessions on InMotion® robotic devices nationwide since the launch of the proprietary data platform last year. Over that same period, the hospitals also experienced:

? 58% increase in total session hours (time spent by patients utilizing


    InMotion® robots)



? 47% increase in total number of patients using InMotion® robots

? 65% increase in individual patient treatment time

? 47% increase in number of patient repetitions (movements)

? Three consecutive quarters of patient session growth from Q4 2020 through Q2

of 2021.

A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including Exhibit 99.1).

Item 9.01 Financial Statements and Exhibits.






Exhibit    Description
  99.1       Press Release
104        Cover Page Interactive Data File (embedded within the Inline XBRL document)

© Edgar Online, source Glimpses